rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2006-3-13
|
pubmed:abstractText |
The aim of the present study was to determine whether inhibition of reduced nicotinamide adenine dinucleotide (phosphate) [NAD(P)H] oxidase and of various superoxide generating systems could affect the collagen production, the mRNA and protein expression of collagen types I and III in control and angiotensin II-treated cardiac fibroblasts.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Acetophenones,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type I,
http://linkedlifedata.com/resource/pubmed/chemical/Collagen Type III,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/NADP,
http://linkedlifedata.com/resource/pubmed/chemical/NADPH Oxidase,
http://linkedlifedata.com/resource/pubmed/chemical/Onium Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Reactive Oxygen Species,
http://linkedlifedata.com/resource/pubmed/chemical/Tissue Inhibitor of...,
http://linkedlifedata.com/resource/pubmed/chemical/acetovanillone,
http://linkedlifedata.com/resource/pubmed/chemical/diphenyleneiodonium
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0263-6352
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
757-66
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16531806-Acetophenones,
pubmed-meshheading:16531806-Angiotensin II,
pubmed-meshheading:16531806-Animals,
pubmed-meshheading:16531806-Cells, Cultured,
pubmed-meshheading:16531806-Collagen,
pubmed-meshheading:16531806-Collagen Type I,
pubmed-meshheading:16531806-Collagen Type III,
pubmed-meshheading:16531806-Enzyme Inhibitors,
pubmed-meshheading:16531806-Fibroblasts,
pubmed-meshheading:16531806-Gene Expression,
pubmed-meshheading:16531806-Male,
pubmed-meshheading:16531806-Matrix Metalloproteinase 1,
pubmed-meshheading:16531806-Myocardium,
pubmed-meshheading:16531806-NADP,
pubmed-meshheading:16531806-NADPH Oxidase,
pubmed-meshheading:16531806-Onium Compounds,
pubmed-meshheading:16531806-RNA, Messenger,
pubmed-meshheading:16531806-Rats,
pubmed-meshheading:16531806-Rats, Wistar,
pubmed-meshheading:16531806-Reactive Oxygen Species,
pubmed-meshheading:16531806-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:16531806-Tissue Inhibitor of Metalloproteinase-1
|
pubmed:year |
2006
|
pubmed:articleTitle |
Angiotensin II-stimulated collagen production in cardiac fibroblasts is mediated by reactive oxygen species.
|
pubmed:affiliation |
Hypertension and Cardiovascular Rehabilitation Unit, Department of Cardiovascular Diseases, Katholieke Universiteit Leuven (K. U. Leuven), Belgium. paul.lijnen@med.kuleuven.be
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|